Process Industries Mitsubishi Chemical Holdings Corp. Business Summary
Mitsubishi Chemical Holdings Corp. engages in the management of its group companies. It operates through the following segments: Functional Products, Chemicals, Industrial Gas, and Healthcare. The Functional Products segment sells electronics, displays, films, environment and life solutions, molding materials, polymers, chemicals, and new energy to domestic and overseas customers. The Chemicals segment markets methyl methacrylate, petrochemicals, and carbon. The Industrial Gas segment offers gas for the steel, chemical, and electronics industries. The Healthcare segment manufactures and sells pharmaceuticals, diagnostic reagents, and clinical testing products. The company was founded on October 3, 2005 and is headquartered in Tokyo, Japan.
Financial Highlights
Mar 2021
JPY USD Revenue 3,257.53B 30,714.82M Gross Profit 926,249M 8,733.46M Operating income 173,556M 1,636.43M Income before tax 17,268M 162.81M Net income -7,557M -71.25M EBITDA 417,349M 3,935.12M Diluted EPS -5.32 -0.05 Dividends Per Share 24 0.22 Total Assets 5,287.22B 47,848.21M Total liabilities 3,716.08B 33,629.68M Total equity 1,236.33B 11,188.58M Operating cash flow 467,133M 4,404.52M Currency in JPY Currency in USD
Historical Data Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Revenue
3,376.05B
3,724.40B
3,840.34B
3,580.51B
3,257.53B
Gross Profit
1,009.39B
1,120.06B
1,074.52B
987,263M
926,249M
Operating income
287,903M
355,745M
297,750M
186,691M
173,556M
Income before tax
241,379M
344,077M
284,846M
122,003M
17,268M
Net income
153,673M
211,788M
167,058M
37,185M
-7,557M
EBITDA
461,943M
534,640M
497,082M
426,515M
417,349M
Diluted EPS
105.95
136.05
110.04
35.20
-5.32
Dividends Per Share
20
32
40
32
24
Total Assets
4,463.54B
4,701.41B
5,572.50B
5,132.14B
5,287.22B
Total liabilities
2,765.35B
2,781.92B
3,546.65B
3,681.32B
3,716.08B
Total equity
1,091.39B
1,285.75B
1,377.94B
1,170.22B
1,236.33B
Operating cash flow
396,643M
397,940M
415,575M
452,003M
467,133M
Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Revenue
31,176.79M
33,603.94M
34,630.52M
32,931.56M
30,714.82M
Gross Profit
9,321.47M
10,105.90M
9,689.62M
9,080.30M
8,733.46M
Operating income
2,658.69M
3,209.75M
2,684.98M
1,717.08M
1,636.43M
Income before tax
2,229.05M
3,104.47M
2,568.61M
1,122.11M
162.81M
Net income
1,419.12M
1,910.88M
1,506.45M
342.00M
-71.25M
EBITDA
4,265.89M
4,823.85M
4,482.46M
3,922.85M
3,935.12M
Diluted EPS
0.97
1.22
0.99
0.32
-0.05
Dividends Per Share
0.18
0.28
0.36
0.29
0.22
Total Assets
40,056.95M
44,206.99M
50,345.65M
47,539.70M
47,848.21M
Total liabilities
24,816.92M
26,158.19M
32,042.77M
34,100.50M
33,629.68M
Total equity
9,794.47M
12,089.79M
12,449.26M
10,839.90M
11,188.58M
Operating cash flow
3,662.86M
3,590.46M
3,747.47M
4,157.27M
4,404.52M
Valuation Measures
Mar 2021
PER -- ROA -0.14% ROE -0.62% Operating margin 5.32% Profit margin -0.23%
Key executives
President & Representative Director:
Jean-Marc Gilson
CFO, Director & Managing Executive Officer:
Hidefumi Date
Director & Chief Compliance Officer:
Ken Fujiwara
Executive Officer, Head-Mergers & Acquisitions:
Tsutomu Yoshida
Group Manager-Business Administration Office:
Hajime Komori Shareholders
Mitsubishi Chemical Holdings Corp. (5.4%)
Meiji Yasuda Life Insurance Co. (4.2%)
Sumitomo Mitsui Trust Asset Management Co., Ltd. (4.1%)
Mitsubishi UFJ Trust & Banking Pension Fund (3.8%)
Nomura Asset Management Co., Ltd. (3.8%)
Nippon Life Insurance Co. (2.8%)
BlackRock Fund Advisors (2.5%)
Nikko Asset Management Co., Ltd. (2.2%)
The Vanguard Group, Inc. (2.1%)
Mitsubishi UFJ Financial Group, Inc. (1.8%)
Related Companies
Mitsubishi Chemical Hldgs. Restricted Stock Compensation Plan
Nippon Gases Euro-Holdings SL
MCPP Innovation LLC
Diamond Edge Ventures, Inc.
Mitsubishi Chemical Holdings Board Incentive Plan
Verbatim Corp.
Mitsubishi Chemical Imaging Corp.
MEP Technical Center Asia Ltd.
MCC Group Holdings (UK) Ltd.
Life Science Institute, Inc.
Mitsubishi Chemical Holdings Europe GmbH
AmperVertice Lda.
Mitsubishi Plastics Agricultural Film Technology Wuxi Co. Ltd.
Ryoukou Industrial Co. Ltd.
Mitsubishi Chemical Analysis Co. Ltd.
Rhombic Corp. (Japan)
Verbatim Southern Africa
Mitsubishi Chemical Holdings (Beijing) Co. Ltd.
Tai Young High Tech Co. Ltd.
MCC PTA Asia Pacific Pte Ltd.
Mitsubishi Chemical Holdings America, Inc.
Advanced Plastics Compounds Singapore Pte Ltd.
PT Mitsubishi Chemical Indonesia
Yoshitomi Engineering Ltd.
Mitsubishi Chemical Hldgs Business Association
Kaiteki Institute, Inc.
Mitsubishi Chemical Infonics Pte Ltd.
Nihon Gosei Sangyo KK
Ryoju Corp.
Mitsubishi Chemical Agri, Inc.
Competitors
LG Chem Ltd.
DuPont de Nemours, Inc.
Sumitomo Chemical Co., Ltd.
Eastman Chemical Company
Arkema SA
Linde plc
Kolon Industries, Inc.
Kolon Life Science Inc.
Covestro AG
Sinochem International Corporation Class A
Celanese Corporation
Hebei Cangzhou Dahua Co. Ltd. Class A
UFlex Limited
Polyplex (Thailand) Public Co. Ltd.
Mechema Chemicals International Corp.
Chemocentryx, Inc.
Acorda Therapeutics, Inc.
Adamas Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Class A
Cytokinetics, Incorporated
Shenzhen Capchem Technology Co., Ltd. Class A
Annexon, Inc.
Voyager Therapeutics, Inc.
FibroGen, Inc.
Valneva SE
Ultra Clean Holdings, Inc.
Danimer Scientific, Inc. Class A
Orphazyme A/S
Protalix Biotherapeutics, Inc.
Copyright © 2021 FactSet Research Systems Inc. All rights reserved.
Last Updated on 18 Oct, 2021
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter Find out more
